Natural products as sources of new drugs over the 30 years from 1981 to 2010
- PMID: 22316239
- PMCID: PMC3721181
- DOI: 10.1021/np200906s
Natural products as sources of new drugs over the 30 years from 1981 to 2010
Abstract
This review is an updated and expanded version of the three prior reviews that were published in this journal in 1997, 2003, and 2007. In the case of all approved therapeutic agents, the time frame has been extended to cover the 30 years from January 1, 1981, to December 31, 2010, for all diseases worldwide, and from 1950 (earliest so far identified) to December 2010 for all approved antitumor drugs worldwide. We have continued to utilize our secondary subdivision of a "natural product mimic" or "NM" to join the original primary divisions and have added a new designation, "natural product botanical" or "NB", to cover those botanical "defined mixtures" that have now been recognized as drug entities by the FDA and similar organizations. From the data presented, the utility of natural products as sources of novel structures, but not necessarily the final drug entity, is still alive and well. Thus, in the area of cancer, over the time frame from around the 1940s to date, of the 175 small molecules, 131, or 74.8%, are other than "S" (synthetic), with 85, or 48.6%, actually being either natural products or directly derived therefrom. In other areas, the influence of natural product structures is quite marked, with, as expected from prior information, the anti-infective area being dependent on natural products and their structures. Although combinatorial chemistry techniques have succeeded as methods of optimizing structures and have been used very successfully in the optimization of many recently approved agents, we are able to identify only one de novo combinatorial compound approved as a drug in this 30-year time frame. We wish to draw the attention of readers to the rapidly evolving recognition that a significant number of natural product drugs/leads are actually produced by microbes and/or microbial interactions with the "host from whence it was isolated", and therefore we consider that this area of natural product research should be expanded significantly.
Figures
![Figure 1](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3721181/bin/nihms356104f1.gif)
![Figure 2](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3721181/bin/nihms356104f2.gif)
![Figure 3](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3721181/bin/nihms356104f3.gif)
![Figure 4](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3721181/bin/nihms356104f4.gif)
![Figure 5](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3721181/bin/nihms356104f5.gif)
![Figure 6](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3721181/bin/nihms356104f6.gif)
![Figure 7](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3721181/bin/nihms356104f7.gif)
![Figure 8](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3721181/bin/nihms356104f8.gif)
![Figure 9](https://www.ncbi.nlm.nih.gov/pmc/articles/instance/3721181/bin/nihms356104f9.gif)
Similar articles
-
Folic acid supplementation and malaria susceptibility and severity among people taking antifolate antimalarial drugs in endemic areas.Cochrane Database Syst Rev. 2022 Feb 1;2(2022):CD014217. doi: 10.1002/14651858.CD014217. Cochrane Database Syst Rev. 2022. PMID: 36321557 Free PMC article.
-
Natural Products as Sources of New Drugs over the Nearly Four Decades from 01/1981 to 09/2019.J Nat Prod. 2020 Mar 27;83(3):770-803. doi: 10.1021/acs.jnatprod.9b01285. Epub 2020 Mar 12. J Nat Prod. 2020. PMID: 32162523 Review.
-
Natural Products as Sources of New Drugs from 1981 to 2014.J Nat Prod. 2016 Mar 25;79(3):629-61. doi: 10.1021/acs.jnatprod.5b01055. Epub 2016 Feb 7. J Nat Prod. 2016. PMID: 26852623 Review.
-
Natural products as sources of new drugs over the last 25 years.J Nat Prod. 2007 Mar;70(3):461-77. doi: 10.1021/np068054v. Epub 2007 Feb 20. J Nat Prod. 2007. PMID: 17309302 Review.
-
Natural products as sources of new drugs over the period 1981-2002.J Nat Prod. 2003 Jul;66(7):1022-37. doi: 10.1021/np030096l. J Nat Prod. 2003. PMID: 12880330 Review.
Cited by
-
Ethanolic Extract from Fruits of Pintoa chilensis, a Chilean Extremophile Plant. Assessment of Antioxidant Activity and In Vitro Cytotoxicity.Plants (Basel). 2024 May 18;13(10):1409. doi: 10.3390/plants13101409. Plants (Basel). 2024. PMID: 38794478 Free PMC article.
-
Advances on anticancer fungal metabolites: sources, chemical and biological activities in the last decade (2012-2023).Nat Prod Bioprospect. 2024 May 14;14(1):31. doi: 10.1007/s13659-024-00452-0. Nat Prod Bioprospect. 2024. PMID: 38743184 Free PMC article.
-
Exploring CDKN1A Upregulation Mechanisms: Insights into Cell Cycle Arrest Induced by NC2603 Curcumin Analog in MCF-7 Breast Cancer Cells.Int J Mol Sci. 2024 May 3;25(9):4989. doi: 10.3390/ijms25094989. Int J Mol Sci. 2024. PMID: 38732206 Free PMC article.
-
Unveiling the Potential of Ent-Kaurane Diterpenoids: Multifaceted Natural Products for Drug Discovery.Pharmaceuticals (Basel). 2024 Apr 16;17(4):510. doi: 10.3390/ph17040510. Pharmaceuticals (Basel). 2024. PMID: 38675469 Free PMC article. Review.
-
Integrated algal and oil palm biorefinery as a model system for bioenergy co-generation with bioproducts and biopharmaceuticals.Bioresour Bioprocess. 2021 May 20;8(1):40. doi: 10.1186/s40643-021-00396-0. Bioresour Bioprocess. 2021. PMID: 38650258 Free PMC article. Review.
References
-
- Cragg GM, Newman DJ, Snader KM. J Nat Prod. 1997;60:52–60. - PubMed
-
- Newman DJ, Cragg GM, Snader KM. J Nat Prod. 2003;66:1022–1037. - PubMed
-
- Newman DJ, Cragg GM. J Nat Prod. 2007;70:461–477. - PubMed
-
- Cragg GM, Grothaus PG, Newman DJ. Chem Rev. 2009;109:3012–3043. - PubMed
-
- Newman DJ, Cragg GM. In: Functional Molecules from Natural Sources. Wrigley SK, Thomas R, Nicholson N, Bedford C, editors. RSC Publications; Cambridge, UK: 2010. pp. 3–36.
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources